Thank You

Error.

An error has occurred and your email has not been sent.
Please try again.

Updated Feb. 12, 2011 12:01 a.m. ET

13Ds are filed with the Securities and Exchange Commission within 10 days of an entity's attaining a greater than 5% position in any class of a company's securities. Subsequent changes in holdings or intentions must be reported in amended filings. This material has been extracted from filings released by the SEC from Feb. 3 through Feb. 9, 2011. Source: InsiderScore.com

Activist Filings

On Feb. 1, MMI Investments delivered a letter to the board of EMS, disclosing its plan to submit a slate of four director nominees via an alternate proxy statement at the company's annual shareholder meeting. MMI owns 1,184,700 EMS shares (7.7% of the total outstanding).

The company acceded to a request by Kensico Capital Management to nominate one or more directors at its coming 2011 shareholder meeting, the fund group disclosed in a filing. Kensico owns 6,974,844 shares (10.2%).

Angelo, Gordon & Co. disclosed that it owns 4,628,325 shares (17.62%). The fund purchased $356.5 million in bank debt from the company, and $34 million in creditor claims against it during a one-year period that ended in May 2010.

Fairpoint, which filed for Chapter 11 bankruptcy protection in October 2009, submitted a reorganization plan that was accepted on Jan. 13 of this year. Under its provisions, the purchase of the bank debt entitles Angelo, Gordon to 4,064,778 shares, while the purchase of the claims entitles it to an additional 563,547.

Business: Provides software and hardware design products. Investor's Average Cost: $11.73 per share (Casablanca Capital), $9.08 (Carl Icahn) Stock-Market Value: $1.55 billion ($14.11 per share) What's Happening: Casablanca and Icahn each intend to nominate competing slates of directors at the 2011 annual meeting. Icahn also has stated that he believes that the company should put itself up for sale.

Key Numbers: 14.7%: percentage of common stock owned by Icahn 5.5%: percentage of common owned by Casablanca Less than 1%: percentage owned by the board and executive officers (excluding stock options)

Behind the Scenes: Icahn and Casablanca aren't acting as a group and can't do so without triggering the company's poison pill.

If Icahn and Casablanca both go through with their proxy fights, they will cannibalize each other, and they will not let that happen. More likely, either one or both will settle with the company and agree to support a mixed slate of director nominees. Or Icahn and Casablanca will rely on a no-action letter that Icahn received in 2009 from the SEC's Division of Corporation Finance in connection with a previous proxy fight that allowed two dissident shareholders to use the company's nominees and the other dissident's nominees to fill out their slate of directors. That would allow Icahn, for example, to solicit proxies that effectively would vote for his three nominees and a pre-specified combination of some Casablanca nominees and some company' nominees to fill out the other five seats. And Casablanca could do the same thing in its proxy solicitation.

-- Kenneth Squire

This item is by 13D Monitor, a research firm specializing in shareholder activism and 13D filings. For a full report, go to www.13DMonitor.com or call Kenneth Squire at 1-212-223-2282.